Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001079973-25-000265·L1 Capital Global Opportunities Master Fund, Ltd.
Schedule 13G ownership disclosure
SUNSHINE BIOPHARMA INC
Common Stock, $0.001 par value · CUSIP: 867781403
Event date: 2024-12-31
- Filing-level shares
- 142,244.00
- Percent of class
- 4.99%
- L1 Capital Global Opportunities Master Fund, Ltd.
Shares: 142,244.00 · Class: 4.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001079973-25-000265
- Form type
- SCHEDULE 13G/A
- Filer
- L1 Capital Global Opportunities Master Fund, Ltd.
- CIK
- CIK 1702202
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership